In part two of our series on the future of ATMPs, Marco Flori, Global Account Manager at Staubli Robotic UK, and Dan Strange, CTO and Co-founder of Cellular Origins, join the podcast to share more about the potential and benefits of automation and robotics in the production of cellular and gene therapies.